Promoting and maintaining patient safety and the quality of our products is central to Indivior’s culture and patient-focused business model. Indivior maintains a pharmacovigilance system to monitor the safety of the marketed and investigational products in a thorough manner and comply with laws and regulations relating to pharmacovigilance. This includes maintaining the required documents and training of our workforce members and others required to follow our requirements.
Indivior is committed to capturing and reporting safety information associated with our products, in full compliance with laws and regulations globally.
Further, Indivior continues to work actively alongside regulatory authorities to combat counterfeiting. This includes a vigilant and active Risk Evaluation Mitigation Strategy (REMS) program for relevant products.
